Ireland
--:--IST
Recruiting Not applicable

Effects of Nurse-Guided BBTi for Improving Insomnia : in Patients at the Recovery Following Traumatic Brain Injury

NCT05402761 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2022-08-15
Last updated
2026-03-31

Condition(s) studied

InsomniaTraumatic Brain Injury

Investigational drug(s) / intervention(s)

Nurse-guided BBTi groupMobile-delivered BBTi group

Nurse-guided BBTi group: On the arrival for the baseline appointment, participants will receive workbooks which include an outline and content of BBTi. In the end of week 1 and 3, nurse interventionist will meet participants to review their sleep diary data and negotiate their bedtime and wake-time schedule. During the weeks 2 and 4, participants will receive planned follow-up phone calls to assess their adherence and review progress and challenges.

Mobile-delivered BBTi group: They will use the app in conjunction with the standard BBTi procedures provided by the app, such as stimulus control, sleep restriction and audio-guided relaxation techniques (suggest to use before bedtime).

Study summary

nsomnia is a frequent complaint reported by patients with TBI, and exacerbates their ability to return to productive activity, which subsequently elevate related healthcare costs and burden. Existing literatures found that effects of CBTi, first-line therapy for insomnia, on post-traumatic insomnia is still debated, indicating that developing an alternative nonpharmacological therapy for alleviating insomnia following TBI is required. Besides, digital health is one of strategies to achieve precision health. Thus far, knowledge regarding whether mobile-delivered BBTi has non-inferiority effects as BBTi in treating insomnia is still lacking. Therefore, a RCT with a large sample size to examine the immediate and lasting effects of BBTi and mobile-delivered BBTi on insomnia, mood disturbances, and cognitive dysfunctions in patients following TBI at the recovery stage compared with the control participants.

Eligibility

Sex
ALL
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * have received a diagnosis of TBI at least 3 months before enrollment (TBI in chronic stage), * yield an initial (i.e., rated in the emergency room) GCS score of 3-15 (mild to severe) and have GCS score of 15 when enrolling into the study, * report lying awake for ≥30 min a night for ≥3 nights per week for ≥3 months, * have post-TBI insomnia with a total score \> 7 on the Chinese version of the insomnia severity scale (CISI) at screening, * be able to communicate in Mandarin Chinese, and be able to complete cognitive tasks (having Rancho Los Amigos Levels of Cognitive Functioning scale score \> 9) Exclusion Criteria: * include premorbid diagnoses of seizure, * sleep disorders (e.g., sleep apnea, screened by using the STOP-Bang questionnaire with a score \> 3), * psychiatric diseases, * substance abuse, * alcoholism * Shift workers and women who are pregnant, breastfeeding, or in the menopausal transition

Primary outcome measure(s)

  • Changes in Insomnia Severity — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    The ISI consists of seven items, and each item can be rated from 0 to 4, resulting in total score ranging from 0 to 28, with higher scores indicating greater insomnia severity. A cutoff score of \> 7 is used to diagnose subthreshold insomnia.
  • Changes in Sleep quality — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    Sleep quality will be measured by Pittsburgh Sleep Quality Index (PSQI). PSQI has 18 questions to evaluate sleep condition. The score range from 0-21, if score\>5 is associated with poor sleep. The higher score means poorer sleep quality.
  • Changes in Daytime Sleepiness — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    Daytime Sleepiness will be measured by Epworth Sleepiness Scale (ESS). ESS has 8 questions to evaluate the condition of dozing off or falling asleep. The score range from 0-24, if score\>10 is associated with daytime sleepiness.
  • Changes in Sleep parameters from sleep logs: sleep onset latency(SOL) — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    Sleep onset latency(SOL) is the time of duration from lying on bed to fall asleep. SOL shorter than 30 minutes is one of criteria of good sleep condition.
  • Changes in Sleep parameters from sleep logs: after sleep onset(WASO) — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    Wake after sleep onset(WASO) is the total time of wakefulness after sleep onset. WASO less than 30 minutes is one of criteria of good sleep condition.
  • Changes in Sleep parameters from sleep logs: total sleep time(TST) — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    Total sleep time(TST) is the total time of falling asleep. TST will be used to calculate sleep efficiency(SE).
  • Changes in Sleep parameters from sleep logs: sleep efficiency(SE) — at baseline and the 5th week and the 12th week after intervention finished and the 24th week after intervention finished
    Sleep efficiency(SE) is the percentage of total sleep time to time in bed. A good sleep condition should meet the criteria of SE greater than 85%.

Trial sites (2)

FacilityCityRegionStatus
Taipei Medical University Taipei Taiwan Recruiting
Skin Kong International Health Center Taipei Taiwan Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05402761 on ClinicalTrials.gov ↗ ← All trials in Taiwan